13hon MSN
Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026
Q4 2025 Management View Arun Menawat, Chairman & CEO, emphasized the completion of recruitment for CAPTAIN, the first multicenter, randomized, controlled trial comparing a new technology to robotic ...
Profound is building the marketing infrastructure for an internet where brand discovery is mediated by AI. The company has rapidly become a critical platform for enterprises globally as Answer Engines ...
Avenue Z, the hybrid agency pioneering AI Search Optimization (AEO), has been selected to co-lead a featured workshop at SXSW 2026 alongside Profound, the marketing platform for the era of AI, ...
Investors might want to bet on Profound Medical (PROF), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...
Artificial intelligence discovery monitoring platform company Profound today announced that it had raised $96 million in new ...
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Profound, the marketing platform for the era of AI, enabling brands to understand, control, and scale how they appear across AI Search, announced it has ...
Profound Medical Corp. remains rated Sell due to persistent competitive pressures, missed growth promises, and deteriorating financials. PROF's recent 20% stock spike followed news of a Dallas Medical ...
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results